Trulieve Cannabis (TRLV) Accounts Payables (2020 - 2026)

Trulieve Cannabis (TRLV) has reported Accounts Payables for 7 consecutive years, with $78.9 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Accounts Payables fell 13.4% year-over-year to $78.9 million; the TTM figure through Mar 2026 stood at $78.9 million (down 13.4% YoY), while the FY2025 annual figure was $82.7 million, down 12.1% from the prior year.
• Accounts Payables came in at $78.9 million for Q1 2026 at Trulieve Cannabis, down from $82.7 million in the prior quarter.
• The five-year high for Accounts Payables was $96.1 million in Q3 2024, with the low at $14.6 million in Q1 2022.
• Average Accounts Payables over 5 years is $81.1 million, with a median of $83.2 million recorded in 2023.
• The largest YoY upside for Accounts Payables was 855.76% in 2022 against a maximum downside of 65.18% in 2022.
• Year by year, Accounts Payables stood at $82.0 million in 2022, then gained by 1.39% to $83.2 million in 2023, then grew by 13.08% to $94.0 million in 2024, then fell by 12.1% to $82.7 million in 2025, then fell by 4.51% to $78.9 million in 2026.
• According to Business Quant data, Accounts Payables over the past three periods registered $78.9 million, $82.7 million, and $81.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.